Log In
Monday 28th May 2018

French drug advertising

15th February 2007

Attempts to undermine the drugs advertising ban across Europe have failed in France.


Patient compliance support programmes are intended to increase compliance in drug use, and reduce complications, by using methods such as telephone reminders, personalised information, and even home visits from nurses, say drug companies who have campaigned to make them legal. 

However a recently formed advocacy group, made up of patients and healthcare professionals has successfully lobbied French politicians, arguing that compliance programmes are little more than covert marketing strategies, designed to build brand loyalty to particular drugs, and are an attempt by the pharmaceutical industry to introduce direct patient advertising by the back door. 

Direct advertising of drugs to patients, seen extensively in the US, is currently banned across Europe.  Despite this recent victory to protect the ban, it will be debated in the French parliament later this year.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018